- Home
- CCB vs ABUS Comparison
CCB vs ABUS Comparison
Compare CCB & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCB
- ABUS
- Stock Information
- Founded
- CCB 1997
- ABUS N/A
- Country
- CCB United States
- ABUS United States
- Employees
- CCB N/A
- ABUS N/A
- Industry
- CCB Major Banks
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- CCB Finance
- ABUS Health Care
- Exchange
- CCB Nasdaq
- ABUS Nasdaq
- Market Cap
- CCB 811.4M
- ABUS 697.3M
- IPO Year
- CCB 2018
- ABUS N/A
- Fundamental
- Price
- CCB $79.54
- ABUS $3.20
- Analyst Decision
- CCB Strong Buy
- ABUS Strong Buy
- Analyst Count
- CCB 2
- ABUS 4
- Target Price
- CCB $84.50
- ABUS $5.50
- AVG Volume (30 Days)
- CCB 116.7K
- ABUS 772.0K
- Earning Date
- CCB 01-28-2025
- ABUS 11-06-2024
- Dividend Yield
- CCB N/A
- ABUS N/A
- EPS Growth
- CCB N/A
- ABUS N/A
- EPS
- CCB 2.98
- ABUS N/A
- Revenue
- CCB $284,123,000.00
- ABUS $6,742,000.00
- Revenue This Year
- CCB N/A
- ABUS N/A
- Revenue Next Year
- CCB $27.25
- ABUS N/A
- P/E Ratio
- CCB $28.31
- ABUS N/A
- Revenue Growth
- CCB 8.86
- ABUS N/A
- 52 Week Low
- CCB $35.67
- ABUS $2.20
- 52 Week High
- CCB $86.27
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- CCB 58.10
- ABUS 40.38
- Support Level
- CCB $73.80
- ABUS $3.59
- Resistance Level
- CCB $86.27
- ABUS $3.61
- Average True Range (ATR)
- CCB 2.80
- ABUS 0.14
- MACD
- CCB 0.09
- ABUS -0.00
- Stochastic Oscillator
- CCB 46.03
- ABUS 15.12
About CCB Coastal Financial Corporation
Coastal Financial Corp is a financial service provider. The company provides banking products and services to consumers and small to medium-sized businesses. Its business is conducted through three reportable segments: The community bank, CCBX, and treasury & administration. The primary focus of the community bank is on providing a wide range of banking products and services to consumers and small to medium-sized businesses in the broader Puget Sound region in the state of Washington and through the Internet and mobile banking applications.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.